BiomX logo

BiomX

BiomX is a biotechnology company developing phage therapies for eradicating bacteria associated with chronic diseases.

3

Funding Rounds

$80.0m

Money raised

Overview

BiomX is a biotechnology company developing phage therapies for eradicating bacteria associated with chronic diseases.

Funding series

Funding Series Analysis

The company BiomX has raised a total of $24m in funding over 3 rounds.

Key Insights:

  • BiomX Series A round, May 2017: $24m
  • BiomX funding round, May 2017: $24m
  • BiomX Ltd funding round, February 2019: $32m
BiomX logo
BiomX Series A round, May 2017 $24m
BiomX logo
BiomX funding round, May 2017 $24m
BiomX logo
BiomX Ltd funding round, February 2019 $32m

Industries

BiomX is active in the following industries:
  • Therapeutics
  • Drug discovery
  • Microbiome
  • Biomedical engineering
  • Pharmaceutical industry
  • Biopharmaceutical
  • Technology
  • Synthetic biology
  • Biology
  • Biotechnology
  • Engineering
  • Healthcare